Skip to main navigation Skip to search Skip to main content

Validation Of LRRK2 Modifiers As Potential PD Therapeutic Targets - Joint with Universite de Lille and University of Padua

Project Details

StatusFinished
Effective start/end date26/06/2331/12/25